Search - tctmd.com

Displaying 301 - 320 of 330

Sort: Relevancy | Date

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Conference News CRT 2017

Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases

Michael O'Riordan

February 21, 2017

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

News Daily News

Edwards Lifesciences Pauses Transcatheter Mitral Valve Study to Work Out Design Issues

Michael O'Riordan

February 07, 2017

News Daily News

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Michael O'Riordan

January 26, 2017

News Features

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Michael O'Riordan

January 24, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

News Daily News

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Michael O'Riordan

December 19, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Daily News

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

Michael O'Riordan

August 18, 2016

News Daily News

简单风险评分系统预测 TAVR 后死亡率

Michael O'Riordan

July 25, 2016

News Daily News

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Michael O'Riordan

July 25, 2016

News Daily News

Simple Risk-Scoring System Predicts Mortality After TAVR

Michael O'Riordan

July 25, 2016

News Daily News

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

Michael O'Riordan

July 05, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Michael O'Riordan

July 05, 2016

Advertisement

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Edwards Lifesciences Pauses Transcatheter Mitral Valve Study to Work Out Design Issues

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

简单风险评分系统预测 TAVR 后死亡率

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Simple Risk-Scoring System Predicts Mortality After TAVR

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content